These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Hydroxyurea, sickle cell disease and renal transplantation. Allen A, Scoble J, Snowden S, Hambley H, Bellingham A. Nephron; 1997 Jan 27; 75(1):106-7. PubMed ID: 9031282 [No Abstract] [Full Text] [Related]
10. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature]. Nkashama GM, Wakamb GK, Mulangu AM, Nkashama GM, Kupa BK, Numbi OL. Pan Afr Med J; 2015 Jan 27; 21():124. PubMed ID: 26327961 [Abstract] [Full Text] [Related]
13. Hydroxyurea in very young children with sickle cell anemia is not a cure-all. Powars DR. J Pediatr; 2001 Dec 27; 139(6):763-4. PubMed ID: 11743496 [No Abstract] [Full Text] [Related]
14. Hydroxycarbamide use in young children with sickle-cell anaemia. Obaro SK, Inusa B, Telfer P. Lancet; 2011 Nov 19; 378(9805):1777. PubMed ID: 22098850 [No Abstract] [Full Text] [Related]
15. Hydroxycarbamide use in young children with sickle-cell anaemia. Takahashi Y, Mori J, Tsubokura M, Matsumura T, Kami M. Lancet; 2011 Nov 19; 378(9805):1777. PubMed ID: 22098851 [No Abstract] [Full Text] [Related]
17. Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease. Hoppe C, Vichinsky E, Quirolo K, van Warmerdam J, Allen K, Styles L. J Pediatr Hematol Oncol; 2000 Jul 03; 22(4):330-4. PubMed ID: 10959903 [Abstract] [Full Text] [Related]
18. The effect of hydroxcarbamide therapy on survival of children with sickle cell disease. Lobo CL, Pinto JF, Nascimento EM, Moura PG, Cardoso GP, Hankins JS. Br J Haematol; 2013 Jun 03; 161(6):852-60. PubMed ID: 23590693 [Abstract] [Full Text] [Related]